404 Oops, we can't find that page! Here are some helpful links instead: Home About Careers Explore - Research and Analysis Explore - Events Explore - Programs Explore - Videos
Sara Latham is a communications expert with more than 20 years’ experience in advising elected officials, businesses and foundations. She is one of a few Americans to have served as a political appointee in both the US and UK governments; where she worked for former President Clinton and former Prime Minister Blair. Sara is currently a Managing Partner at freuds, the London strategic communications agency where she oversees global corporate accounts with a particular emphasis on thought leadership and purpose-led initiatives and campaigns. She has a proven ability to lead and thrive in highly scrutinized environments; deliver impactful strategic campaigns spanning business, government and NGOs; and execute specialized stakeholder engagement. Sara recently served as a Senior Adviser on the Hillary for America campaign, where she led the political strategy and execution for the ‘super surrogates, (Obama, Biden, President Clinton) and ran the campaign’s covert running-mate selection process, announcement and general election plan.
Milken was indicted for racketeering and securities fraud in 1989 in an insider trading investigation. As the result of a plea bargain, he pleaded guilty to securities and reporting violations but not to racketeering or insider trading. Milken was sentenced to ten years in prison, fined $600 million, and permanently barred from the securities industry by the Securities and Exchange Commission. His sentence was later reduced to two years for cooperating with testimony against his former colleagues and for good behavior. Supporters, like George Gilder in his book, Telecosm (2000), state that “Milken was a key source of the organizational changes that have impelled economic growth over the last twenty years. Most striking was the productivity surge in capital, as Milken … and others took the vast sums trapped in old-line businesses and put them back into the markets.” Since his release from prison, Milken has funded medical research.
He is co-founder of the Milken Family Foundation, chairman of the Milken Institute, and founder of medical philanthropies funding research into melanoma, cancer and other life-threatening diseases. A prostate cancer survivor, Milken has devoted significant resources to research on the disease. In a November 2004 cover article, Fortune magazine called him “The Man Who Changed Medicine” for changes in approach to funding and results that he initiated. Milken’s compensation, while head of the high-yield bond department at Drexel Burnham Lambert in the late 1980s, exceeded $1 billion in a four-year period, a new record for U.S. income at that time. With an estimated net worth of around $3.7 billion as of 2018, he is ranked by Forbes magazine as the 606th richest person in the world.